Credo Technology Stock Is Soaring. Is This a Top AI Play for 2026?

Credo Technology, a provider of high-speed data-center connectivity, has surged since its $10 IPO (now ~ $177, roughly +1,700%) as the AI market drove demand for its AECs and SerDes chiplets. Fiscal 2025 revenue growth accelerated 126% with adjusted gross margin at 65% and adjusted operating margin at 26.4%; in H1 fiscal 2026 revenue jumped 273% y/y to $491m, adjusted gross margin rose to 67.6%, adjusted operating margin to 44.9%, and adjusted net income to $226m (GAAP profitable). Management expects Q3 revenue +148–156% y/y and analysts forecast FY2026 revenue +173% and adjusted EPS +301% (FY2027 +37% revenue, +30% EPS), but risks include high valuation (~93x forward adjusted earnings), customer concentration (four hyperscalers >10% each), and competition from larger chipmakers.

Analysis

Market structure: Credo (CRDO) is a direct beneficiary of hyperscaler AI capex — its 224G PAM4 SerDes enabling ~1.6 Tbps ports gives it pricing power in a tight data‑center connectivity stack. Near‑term demand is visible: consensus expects revenue +173% in FY26 and margins expanding to mid‑60s gross, implying cash generation that can accelerate share repurchases or R&D. Upstream winners include TSM (TSM) for N3 capacity and Nvidia (NVDA) indirectly as AI card demand drives ports; legacy low‑speed cable vendors and commodity ICs are losers as buyers trade up.

Competitive dynamics: Credo’s early‑mover advantage can convert to durable share if it sustains N3 supply and customer wins, but Broadcom (AVGO) and Marvell (MRVL) can compress pricing with scale and bundled silicon+software offerings. Customer concentration (four customers >10% each) amplifies revenue volatility — losing one could cut >10% revenue immediately — and TSMC allocation is a choke point that can shift market share rapidly. Expect margin volatility as product mix shifts from AEC to optical and retimers.

Risk assessment: Tail risks include a >30% pullback in hyperscaler AI spend (macro shock or model‑training efficiency gains), a lost top‑4 customer, or TSMC N3 reallocation delaying ramps by 6–12 months; any of these could halve near‑term EPS. Short horizon (days/weeks): earnings beats/misses and supply‑chain comments will swing stock ±20–40% intraday. Long horizon (12–36 months): structural position hinges on sustained AI cluster deployments and Credo winning design‑wins vs AVGO/MRVL.

Trade and contrarian view: Current valuation ~93x forward adjusted EPS prices in near perfection — upside exists but is binary. The market is underestimating execution and wafer‑allocation risk while possibly overrating permanency of triple‑digit growth; this creates opportunities for controlled long exposure hedged by options or relative shorts in larger incumbents with stretched valuations.

Key Decisions for Investors

• Establish a 1–2% portfolio long position in CRDO at market (~$177) and scale to 3% only if price retraces to $120–150 within 3 months (buy the dip threshold). Trim partial position if CRDO > $300 within 12–18 months or if FY26 revenue revision falls >20% yoy.
• Implement a dollar‑neutral pair trade: long CRDO (50%) / short MRVL (50%) sized to 1% net exposure each, holding 6–12 months. Rationale: CRDO’s AI‑specific Se rDes tailwind vs MRVL’s broader exposure and competitive margin pressure; unwind if relative return exceeds +25% or if CRDO misses guidance by >15%.
• If owning shares, buy 12‑month protective puts (e.g., Jan 2027 120P) sized to cover 50% position cost or execute a collar: sell near‑term (3‑6 month) covered calls at ~15–25% OTM to harvest premium while buying 12‑month puts to cap downside to ~30%.
• Use a directional options spread instead of outright LEAPS: buy Jan 2027 200C and sell Jan 2027 350C for a debit spread to cap premium outlay; target 12–18 month time horizon, exit if CRDO < $140 for >30 days or TSMC confirms N3 reallocation away from Credo within 90 days.